Trial Profile
Pregabalin for the treatment of fibromyalgia syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2017
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia; Musculoskeletal pain
- Focus Therapeutic Use
- 16 Nov 2016 Results post-hoc analysis from pooled data of thisa and other two studies presented at the 80th American College of Rheumatology and the 51st Annual Meeting of the Association of Rheumatology and Health Professionals.
- 03 May 2014 Results from a pooled analysis presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 05 Nov 2010 New trial record.